first approved treatment using rnai – alnylam pharmaceuticals’ and bio chair john maraganore
Published 6 years ago • 2.1K plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
2:56
rnai therapeutics - how this new class of medicines works
-
3:27
rnai therapeutics - how this new class of medicines works
-
0:55
what is an rnai therapeutic?
-
1:05
alnylam pharma and the science of rnai
-
2:32
what is rnai and how do rnai-based medicines work?
-
2:19
get to know alnylam - the leader in rnai therapeutics
-
1:02
how do rnai therapeutics treat disease?
-
1:14
john maraganore speaks out on his role as bio chair
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
4:08
rnai: slicing, dicing and serving your cells - alex dainis
-
11:03
rna interference in pest control | biotechnology and its applications | biology | khan academy
-
0:44
silencing disease: shifting treatment paradigms with rnai therapeutics ft. alnylam’s dr. kirk brown
-
3:14
alnylam pharmaceuticals cmo, dr. akshay vaishnaw, explains rnai
-
2:03
alnylam ceo john maraganore speaks about the fight against covid-19
-
2:20
john maraganore on the orion-11 phase 3 results
-
27:33
founder stories: john maraganore, ceo of alnylam pharmaceuticals
-
59:30
founder stories: john maraganore, ceo of alnylam pioneering rnai therapeutics
-
2:01
rnai explained
-
15:44
how alnylam is finally translating rnai into breakthrough medicines? alny stock is soaring
-
2:07
fda approves first-ever rnai-based therapy
-
1:01
alnylam targets “undruggable” diseases
-
2:43
from possibility to patients: the scientific odyssey - the rnai boom